Morepen Laboratories Ltd
NSE:MOREPENLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Morepen Laboratories Ltd
NSE:MOREPENLAB
|
IN |
|
Clicks Group Ltd
OTC:CLCGY
|
ZA |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Dole PLC
NYSE:DOLE
|
IE |
|
Legal & General Group PLC
LSE:LGEN
|
UK |
|
Quanta Services Inc
NYSE:PWR
|
US |
|
Mercedes Benz Group AG
OTC:MBGYY
|
DE |
|
K
|
KPJ Healthcare Bhd
KLSE:KPJ
|
MY |
|
Klaveness Combination Carriers ASA
F:36K
|
NO |
Wall St Price Targets
MOREPENLAB Price Targets Summary
Morepen Laboratories Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MOREPENLAB's stock price target?
Not Available
MOREPENLAB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Morepen Laboratories Ltd?
Projected CAGR
-15%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is -15%.
What is the Gross Profit forecast for Morepen Laboratories Ltd?
Projected CAGR
-27%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 7 years is -27%.
What is the Operating Income forecast for Morepen Laboratories Ltd?
Projected CAGR
-10%
The compound annual growth rate for Operating Income over the next 7 years is -10%.
What is the Pre-Tax Income forecast for Morepen Laboratories Ltd?
Projected CAGR
-20%
The compound annual growth rate for Pre-Tax Income over the next 7 years is -20%.
What is the Net Income forecast for Morepen Laboratories Ltd?
Projected CAGR
-17%
The compound annual growth rate for Net Income over the next 7 years is -17%.
